NCT04792333View on ClinicalTrials.gov

Pharmacokinetics in End Stage Renal Disease Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

July 10, 2020

Study Completion Date

July 10, 2020

Conditions
Healthy VolunteersRenal Failure
Interventions
DRUG

firibastat

Single oral dose of 500 mg administration on Day 1

Trial Locations (1)

38610

Eurofins Optimed, Gières

All Listed Sponsors
collaborator

Eurofins Optimed

INDUSTRY

lead

Quantum Genomics SA

INDUSTRY

NCT04792333 - Pharmacokinetics in End Stage Renal Disease Patients | Biotech Hunter | Biotech Hunter